Lyka Labs secures Indian patent for Pregabalin Gel 8%
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Pflow is a revolutionary, disposable, and portable home based urine flow measurement test
Lyka has received the CDSCO approval for manufacturing and marketing of Pregabalin Gel 8% w/w
This license will enable Abbott to enhance access to this novel therapy to more patients across India
The pooled prevalence of GERD in the Indian population is 15.6 %
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Subscribe To Our Newsletter & Stay Updated